8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Join Veristat and more than 2,500 professionals from biotech, pharma, finance, and life sciences industry across Europe’s most innovative biopharma clusters at the Bio Europe Autumn 2022 event.
Charlotte Smerdon, Veristat Cell & Gene Centre of Excellence Lead and Portfolio Director will be part of the Cell and Gene Panel taking place Monday 24th October at 1:00 PM " From bench to beside: the unique clinical pathway of CGT products"
With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.
We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Website: https://informaconnect.com/bioeurope/
24th-26th October 2022 , Leipzig, Germany.

8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...